Literature DB >> 12468158

Local relapse in patients treated for squamous cell vulvar carcinoma: incidence and prognostic value.

Roman Rouzier1, Bassam Haddad, Francoise Plantier, Philippe Dubois, Monique Pelisse, Bernard Jean Paniel.   

Abstract

To evaluate the risk factors for local relapse in vulvar cancer patients and its impact on survival as a function of its different patterns, which include local recurrences at the primary tumor site, recurrences remote from the primary tumor, and skin bridge recurrences. Between January 1978 and June 1999, 215 patients were treated for vulvar squamous cell carcinoma. The median follow-up was 38 months. To evaluate the role of local relapse in survival, a Cox regression multivariable analysis was performed using local relapse as a time-dependent covariate. The local relapse-free survival rate was 78.6% (+/- 7.1%) at 5 years. Multivariable analyses showed that the local relapse was increased by the factors margin status and depth of invasion. Pathologic nodal status, tumor size, margin status, and depth of invasion were predictors of cancer-related death in the Cox multivariable model with fixed covariates. The contribution of local relapse for disease-specific survival at the site of the primary tumor (relative risk [RR] 6.35; 95% confidence interval [CI] 2.07, 15.76) or skin bridge recurrence (RR 6.48; 95% CI 2.54, 16.49) was highly significant, whereas the contribution of local relapse at the other sites was not (RR 2.29; 95% CI 0.53, 9.91). In this model, margin status was not significant. The risk of cancer-related death after local relapse was 58.4% (+/- 18.3%) at 1 year and 70.9% (+/- 17.6%) at 3 years.Local relapses at the site of the primary tumor or skin bridge recurrences are strong predictors for cancer-related death, but not local relapse at a distant site.

Entities:  

Mesh:

Year:  2002        PMID: 12468158     DOI: 10.1016/s0029-7844(02)02501-2

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  14 in total

1.  Role of adjuvant radiation or re-excision for early stage vulvar squamous cell carcinoma with positive or close surgical margins.

Authors:  Sabrina M Bedell; Chloe Hedberg; Anna Griffin; Hannah Pearson; Annelise Wilhite; Nathan Rubin; Britt K Erickson
Journal:  Gynecol Oncol       Date:  2019-06-03       Impact factor: 5.482

2.  Management of patients with vulvar cancer: a perspective review according to tumour stage.

Authors:  Linn Woelber; Fabian Trillsch; Lilli Kock; Donata Grimm; Cordula Petersen; Matthias Choschzick; Fritz Jaenicke; Sven Mahner
Journal:  Ther Adv Med Oncol       Date:  2013-05       Impact factor: 8.168

3.  Prognostic factors for recurrence and survival in uncommon variants of vulvar cancer.

Authors:  Ignacio Zapardiel; Myriam Gracia; Javier Díez; Alessandro Buda; Maria C Noya; Pierandrea De Iaco; Pedro Vieira-Baptista; Sara Iacoponi
Journal:  Arch Gynecol Obstet       Date:  2020-10-16       Impact factor: 2.344

Review 4.  Recent trends in surgical and reconstructive management of vulvar cancer: review of literature.

Authors:  Salvatore Giovanni Vitale; Gaetano Valenti; Antonio Biondi; Diego Rossetti; Luigi Frigerio
Journal:  Updates Surg       Date:  2015-06-13

5.  Reconstruction of acquired perineovulvar defects: a proposal of sequence.

Authors:  J Joris Hage; Marc van Beurden
Journal:  Semin Plast Surg       Date:  2011-05       Impact factor: 2.314

6.  Adjuvant radiotherapy for vulvar cancer with close or positive surgical margins.

Authors:  Tanja Ignatov; Holm Eggemann; Elke Burger; Serban Dan Costa; Atanas Ignatov
Journal:  J Cancer Res Clin Oncol       Date:  2016-02       Impact factor: 4.553

Review 7.  Surgical management of squamous cell vulvar cancer without clitoris, urethra or anus involvement.

Authors:  Alpaslan Kaban; Işık Kaban; Selim Afşar
Journal:  Gynecol Oncol Rep       Date:  2017-02-10

8.  Prognostic impact of reduced tumor-free margin distance on long-term survival in FIGO stage IB/II vulvar squamous cell carcinoma.

Authors:  Leonardo Micheletti; Mario Preti; Viviana Cintolesi; Elisabetta Corvetto; Silvana Privitera; Eleonora Palmese; Chiara Benedetto
Journal:  J Gynecol Oncol       Date:  2018-04-13       Impact factor: 4.401

9.  Prognostic significance of c-KIT in vulvar cancer: bringing this molecular marker from bench to bedside.

Authors:  Beatriz de Melo Maia; André Mourão Lavorato-Rocha; Iara Sant'ana Rodrigues; Glauco Baiocchi; Flávia Munhoz Cestari; Monica Maria Stiepcich; Ludmila Thomé Domingues Chinen; Kátia C Carvalho; Fernando Augusto Soares; Rafael Malagoli Rocha
Journal:  J Transl Med       Date:  2012-07-28       Impact factor: 5.531

10.  The Clinical Relevance of p16 and p53 Status in Patients with Squamous Cell Carcinoma of the Vulva.

Authors:  Ellen L Barlow; Neil Lambie; Mark W Donoghoe; Zin Naing; Neville F Hacker
Journal:  J Oncol       Date:  2020-03-24       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.